SCHEMBL4745557

SCHEMBL4745557

OC1CCC(O)SC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL140548 0.68
SCHEMBL826227 0.68
SCHEMBL8729166 0.67
SCHEMBL20384339 0.66
SCHEMBL1593359 0.62 TSHR (0.64)
SCHEMBL3389566 0.62 TSHR (0.64)
SCHEMBL102859 0.62
SCHEMBL28182 0.62
SCHEMBL2700308 0.62 TSHR (0.64)
SCHEMBL8036941 0.62 TSHR (0.64)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190211258-A1 PHOTOCHROMIC LENS AND POLYMERIZABLE COMPOSITION MITSUI CHEMICALS, INC. (JP) 2019-07-11 US disclosed
EP-2300518-B1 ANTIREFLECTIVE COATING COMPOSITIONS AZ ELECTRONIC MATERIALS USA (US) 2012-08-15 EP disclosed
EP-2343286-A1 Dibenzo[b,f][1,4]oxazepine derivatives as inhibitors of histone deacetylase Methylgene, Inc. (CA) 2011-07-13 EP disclosed
US-20100249409-A2 PROCESS FOR STEREOSELECTIVE SYNTHESIS OF LAMIVUDINE SHANGHAI DESANO PHARMACEUTICAL HOLDING CO., LTD. (CN) 2010-09-30 US disclosed
US-20100249409-A2 PROCESS FOR STEREOSELECTIVE SYNTHESIS OF LAMIVUDINE SHANGHAI DESANO PHARMACEUTICAL HOLDING CO., LTD. (CN) 2010-09-30 US disclosed
WO-2008120955-A1 COMPOSITION FOR PROTECTING PLANT DISEASES COMPRISING 1,4-DITHIANE-2,5-DIOL AS A BIOCONTROL AGENT AND METHOD FOR CONTROLLING PLANT DISEASE USING THE SAME INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) 2008-10-09 WO disclosed
WO-2008055068-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-05-08 WO disclosed